Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Nov;26(2):547–553. doi: 10.1128/iai.26.2.547-553.1979

Pathogenesis of Marek's disease; effect of immunization with inactivated viral and tumor-associated antigens.

K K Murthy, B W Calnek
PMCID: PMC414651  PMID: 232690

Abstract

Inactivated Marek's disease virus-infected chicken kidney cells and inactivated MSB-1 lymphoblastoid Marek's disease tumor cells were used to immunize chickens as virus- and tumor-associated antigens, respectively. Immune and nonimmune birds were then challenged by exposure to live virulent Marek's disease virus. Both vaccines protected significant numbers of chickens (P less than 0.05) against subsequent tumor development, although viral antigen appeared superior to tumor antigen. After challenge, the early appearance of viral antigen, infected lymphocytes, and degenerative changes in lymphoid organs was inhibited only by the viral antigen vaccine, whereas the early appearance of cells bearing tumor antigen was prevented by both vaccines. These results support the hypothesis that effective immunity in Marek's disease could be directed against either virus replication and spread or events associated with transformation and proliferation of lymphoid cells.

Full text

PDF
552

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Addinger H. K., Calnek B. W. Pathogenesis of Marek's disease: early distribution of virus and viral antigens in infected chickens. J Natl Cancer Inst. 1973 May;50(5):1287–1298. doi: 10.1093/jnci/50.5.1287. [DOI] [PubMed] [Google Scholar]
  2. Akiyama Y., Kato S. Two cell lines from lymphomas of Marek's disease. Biken J. 1974 Sep;17(3):105–116. [PubMed] [Google Scholar]
  3. Calnek B. W., Carlisle J. C., Fabricant J., Murthy K. K., Schat K. A. Comparative pathogenesis studies with oncogenic and nononcogenic Marek's disease viruses and turkey herpesvirus. Am J Vet Res. 1979 Apr;40(4):541–548. [PubMed] [Google Scholar]
  4. Calnek B. W. Effects of passive antibody on early pathogenesis of Marek's disease. Infect Immun. 1972 Aug;6(2):193–198. doi: 10.1128/iai.6.2.193-198.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Chen J. H., Purchase H. G. Surface antigen on chick kidney cells infected with the herpesvirus of Marek's disease. Virology. 1970 Feb;40(2):410–412. doi: 10.1016/0042-6822(70)90421-6. [DOI] [PubMed] [Google Scholar]
  6. Churchill A. E., Payne L. N., Chubb R. C. Immunization against Marek's disease using a live attenuated virus. Nature. 1969 Feb 22;221(5182):744–747. doi: 10.1038/221744a0. [DOI] [PubMed] [Google Scholar]
  7. Cole R. K. Studies on genetic resistance to Marek's disease. Avian Dis. 1968 Feb;12(1):9–28. [PubMed] [Google Scholar]
  8. Else R. W. Vaccinal immunity to Marek's disease in bursectomised chickens. Vet Rec. 1974 Aug 31;95(9):182–187. doi: 10.1136/vr.95.9.182. [DOI] [PubMed] [Google Scholar]
  9. Hahn E. C., Ramos L., Kenyon A. J. Lymphoproliferative diseases of fowl: JM-V leukemic lymphoblasts in cell culture. J Natl Cancer Inst. 1977 Jul;59(1):267–271. doi: 10.1093/jnci/59.1.267. [DOI] [PubMed] [Google Scholar]
  10. Higgins D. A., Calnek B. W. Fowl Immunoglobulins: Quantitation in Birds Genetically Resistant and Susceptible to Marek's Disease. Infect Immun. 1975 Aug;12(2):360–363. doi: 10.1128/iai.12.2.360-363.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hutt F. B., Cole R. K. Genetic Control of Lymphomatosis in the Fowl. Science. 1947 Oct 24;106(2756):379–384. doi: 10.1126/science.106.2756.379. [DOI] [PubMed] [Google Scholar]
  12. Kaaden O. R., Dietzschold B. Immunological tumor prevention of Marek's diseases by plasma membrane vaccines. Bibl Haematol. 1975 Oct;(43):78–80. doi: 10.1159/000399101. [DOI] [PubMed] [Google Scholar]
  13. Lesnik F., Ross L. J. Immunization against Marek's disease using Marek's disease virus-specific antigens free from infectious virus. Int J Cancer. 1975 Jul 15;16(1):153–163. doi: 10.1002/ijc.2910160117. [DOI] [PubMed] [Google Scholar]
  14. Murthy K. K., Calnek B. W. Pathogenesis of Marek's disease: early appearance of Marek's disease tumor-associated surface antigen in infected chickens. J Natl Cancer Inst. 1978 Sep;61(3):849–854. [PubMed] [Google Scholar]
  15. Okazaki W., Purchase H. G., Burmester B. R. Protection against Marek's disease by vaccination with a herpesvirus of turkeys. Avian Dis. 1970 May;14(2):413–429. [PubMed] [Google Scholar]
  16. Payne L. N., Frazier J. A., Powell P. C. Pathogenesis of Marek's disease. Int Rev Exp Pathol. 1976;16:59–154. [PubMed] [Google Scholar]
  17. Powell P. C. Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines. Nature. 1975 Oct 23;257(5528):684–685. doi: 10.1038/257684a0. [DOI] [PubMed] [Google Scholar]
  18. Powell P. C., Payne L. N., Frazier J. A., Rennie M. T lymphoblastoid cell lines from Marek's disease lymphomas. Nature. 1974 Sep 6;251(5470):79–80. doi: 10.1038/251079a0. [DOI] [PubMed] [Google Scholar]
  19. Powell P. C., Rowell J. G. Dissociation of antiviral and antitumor immunity in resistance to Marek's disease. J Natl Cancer Inst. 1977 Sep;59(3):919–924. doi: 10.1093/jnci/59.3.919. [DOI] [PubMed] [Google Scholar]
  20. Purchase H. G. Immunofluorescence in the study of Marek's disease. I. Detection of antigen in cell culture and an antigenic comparison of eight isolates. J Virol. 1969 Jun;3(6):557–565. doi: 10.1128/jvi.3.6.557-565.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rispens B. H., van Vloten H., Mastenbroek N., Maas J. L., Schat K. A. Control of Marek's disease in the Netherlands. II. Field trials on vaccination with an avirulent strain (CVI 988) of Marek's disease virus. Avian Dis. 1972 Apr;16(1):126–138. [PubMed] [Google Scholar]
  22. Ross L. J. Antiviral T cell-mediated immunity in Marek's disease. Nature. 1977 Aug 18;268(5621):644–646. doi: 10.1038/268644a0. [DOI] [PubMed] [Google Scholar]
  23. Schat K. A., Calnek B. W. Protection against Marek's disease-derived tumor transplants by the nononcogenic SB-1 strain of Marek's disease virus. Infect Immun. 1978 Oct;22(1):225–232. doi: 10.1128/iai.22.1.225-232.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Spencer J. L., Calnek B. W. Marek's disease: application of immunofluorescence for detection of antigen and antibody. Am J Vet Res. 1970 Feb;31(2):345–358. [PubMed] [Google Scholar]
  25. Svedmyr E., Jondal M. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1622–1626. doi: 10.1073/pnas.72.4.1622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Witter R. L., Stephens E. A., Sharma J. M., Nazerian K. Demonstration of a tumor-associated surface antigen in Marek's disease. J Immunol. 1975 Jul;115(1):177–183. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES